High-dose chemotherapy with autologous haematopoietic stem cell support for relapsed or refractory primary CNS lymphoma: a prospective multicentre trial by the German Cooperative PCNSL study group

Kasenda, B.; Ihorst, G.; Schroers, R.; Korfel, A.; Schmidt-Wolf, I.; Egerer, G.; von Baumgarten, L.; Roeth, A.; Bloehdorn, Johannes; Moehle, R.; Binder, M.; Keller, U.; Lamprecht, M.; Pfreundschuh, M.; Valk, E.; Fricker, H.; Schorb, E.; Fritsch, K.; Finke, J.; Illerhaus, G.

Erstveröffentlichung

2017

Metadata only
Search for full text

Wissenschaftlicher Artikel

Authors

Kasenda, B.

Ihorst, G.

Schroers, R.

Korfel, A.

Schmidt-Wolf, I.

et al.

Institutions

UKU. Klinik für Innere Medizin III

Published in

Leukemia ; 31 (2017), 12. - S. 2623-2629. - ISSN 0887-6924. - eISSN 1476-5551

Link to publication

https://dx.doi.org/10.1038/leu.2017.170

Funding information

Freiburg University Hospital
Amgen

Keywords

central-nervous-system; recurrent primary cns; intensive chemotherapy; phase-ii; intraocular lymphoma; 1st-line treatment; salvage therapy; clinical-trials; follow-up; transplantation

Dewey Decimal Group

DDC 610 / Medicine & health

Metadata

Show full item record